Enterococcus faecalis surface antigens (E. faecalis surface antigens)

Enterococcus faecalis surface antigens represent a heterogeneous group of molecules, including proteins, lipoteichoic acids (LTA), and capsular polysaccharides, that are anchored to the bacterial cell wall. These antigens are essential for the virulence of E. faecalis, as they facilitate adherence to host extracellular matrix proteins, promote the formation of robust biofilms, and assist in evading the host's innate immune response (PMID: 15105504, PMID: 12670937). Prominent examples include the Enterococcal surface protein (Esp), aggregation substance (AS), and endocarditis- and biofilm-associated pili (Ebp), which are frequently studied as targets for novel therapeutic interventions. In drug development, these antigens are targeted by traditional glycopeptide and lipopeptide antibiotics that disrupt cell wall or membrane assembly, as well as by experimental monoclonal antibodies and vaccines designed to enhance opsonophagocytosis (PMID: 24344353). Given the rise of multidrug-resistant strains like Vancomycin-resistant Enterococci (VRE), these surface components are critical focal points for developing alternative antimicrobial strategies and diagnostic tools.

Other names

Enterococcal surface proteinsE. faecalis cell wall antigensEnterococcus faecalis adhesinsMicrobial surface components recognizing adhesive matrix molecules (MSCRAMMs)Enterococcus faecalis capsular polysaccharides

Inhibition of cell wall peptidoglycan synthesis, disruption of cell membrane integrity through binding to lipoteichoic acid precursors, and promotion of opsonophagocytic killing via monoclonal antibodies or vaccine-induced immunity.